Clinical Trial

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
What if midlife women, who are inherently at an increased risk for future cardiometabolic disease due to transitioning into menopause, had access to a suite of evidence-based health interventions? Could these interventions reduce menopause-related inflammation, restore a healthier cardiometabolic profile, reverse epigenetic aging, and reduce bothersome menopausal symptoms? The ultimate goal of this work is to attenuate future disease and enhance women's quality of life, extend healthspan and increase productivity.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-01
Trial Details
NCT Number NCT06975111
Lead Sponsor University of Colorado, Denver
Conditions Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
Enrollment 200 participants
Start Date 2026-03-01
Primary Completion 2029-10-31 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-21